对α-synuclein基因促进体变异性和帕金森病的合作分析
Demetrius M Maraganore1, Mariza de Andrade, Alexis Elbaz
1Department of Neurology, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA. dmaraganore@mayo.edu
JAMA
|August 10, 2006
概括
帕金森病的风险与SNCA基因的变异有关.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 流行病学 流行病学
背景情况:
- 以前的帕金森病 (PD) 遗传研究受到小样本大小和潜在偏差的限制.
- 阿尔法-同核素 (SNCA) 基因是关键的嫌疑人,但大规模验证是缺失的.
研究的目的:
- 调查SNCA基因促销者REP1等位基因长度变异性与帕金森病易感性之间的关联.
- 为了检查SNCA促销物哈普洛类型是否影响帕金森病风险.
- 为了确定REP1的变异性是否会影响帕金森病发病年龄.
主要方法:
- 来自11个全球站点的个人患者数据的协作分析.
- 在2692例帕金森病病例和2652例对照病例中,SNCA REP1和侧边标记物的基因定型.
- 统计分析包括哈迪-韦恩伯格平衡,异质性测试,关联研究和生存分析.
主要成果:
- 在帕金森病病例和对照组之间观察到SNCA REP1等位基因频率的显著差异 (P<.001).
- SNCA REP1的263个基对等位基与帕金森病风险增加有关 (OR,1.43;P<.001).
- 包括REP1在内的多部位单元类型与帕金森病有关,但REP1的变异性没有影响发病时的年龄 (P = .55).
结论:
- 这项大规模研究证实,SNCA REP1等位基因长度的变异性与帕金森病的风险增加有关.
- 这些发现凸显了SNCA REP1在帕金森病病原体中的重要性.
更多相关视频
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
11.9K
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
10.2K
相关概念视频
Pleiotropy
31.2K
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
31.2K
Incomplete Dominance
19.0K
Gregor Mendel's work (1822 - 1884) was primarily focused on pea plants. Through his initial experiments, he determined that every gene in a diploid cell has two variants called alleles inherited from each parent. He suggested that amongst these two alleles, one allele is dominant in character and the other recessive. The combination of alleles determines the phenotype of a gene in an organism.
19.0K
Comparing Copy Number Variations and SNPs
11.6K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
11.6K
Single Nucleotide Polymorphisms-SNPs
14.6K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.6K
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
